Unlicensed and off-label drug use in children: implications for safety
The DOI matches its Crossref record.
Abstract
Throughout the world, many drugs prescribed for children are used in an offlabel or unlicensed manner. The incidence of unlicensed and off-label drug prescriptions appears to be greatest in critically ill neonates and children and lowest in the general population. The risk associated with unlicensed and off-label drug use appears to be greater than for prescribing in accordance with the product licence. Health professionals, however, usually have no alternative but to use unlicensed and off-label medicines. More clinical trials for medicines in children are required to provide the evidence base for safe and effective drug prescribing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 21
- 10.1136/adc.78.5.402 · DOI
- SUTHERLAND JM, 1959, Am. Dis. Child., 97, 761
- 10.1111/j.1749-6632.1965.tb12261.x · doi:10.1111/j.1749-6632.1965.tb12261.x
- 10.1185/146300902322125109 · doi:10.1185/146300902322125109
- 10.1016/S0140-6736(96)91182-4 · DOI
- 10.1136/bmj.316.7128.343 · DOI · Paper page
- TURNERS NUNN AJ, 1997, Paediam. Perinat. Drug Ther., 1, 52
- 10.1136/bmj.320.7227.79 · DOI · Paper page
- 10.1136/adc.83.6.502 · DOI · Paper page
- 10.1136/bmj.324.7349.1311 · DOI
- 10.1136/bmj.324.7349.1312 · doi:10.1136/bmj.324.7349.1312
- PANDOLFINI C, 2002, Acta Median, 91, 339
- UFER M, 2003, Eur.Pharmacol, 58, 779, 10.1007/s00228-003-0560-z · DOI
- MCKINZIE JP, 1997, Emerg. Med., 15, 118
- 10.1185/1463009001527714 · doi:10.1185/1463009001527714
- 10.1136/adc.83.6.498 · DOI · Paper page
- 10.1136/fn.80.2.F142 · DOI · Paper page
- 10.1111/j.1651-2227.1999.tb00191.x · DOI
- HOREN B, 2002, Br. I Gin. Pharmacol, 54, 665
- 10.1111/j.1651-2227.1995.tb13667.x · DOI
- 10.1136/adc.84.4.337 · DOI
Cited by
Off-label prescribing among office-based physicians
Radley, D. C., Finkelstein, S. N., & Stafford, R. S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.9.1021 · Cited by 711
Development and Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Children
Edginton, A. N., Schmitt, W., & Willmann, S. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645100-00005 · Cited by 357
Osokogu, O. U., Fregonese, F., Ferrajolo, C., Verhamme, K., de Bie, S., Jong, G. ’., Catapano, M., Weibel, D., Kaguelidou, F., Bramer, W. M., et al. (2015) · Drug Safety · doi:10.1007/s40264-015-0265-0 · Cited by 31
“However, such evidence was not mandatory for classification as positive control due to the acknowledged lack of pediatric-specific studies [30].”
Background
Metadata
- Authors
- Choonara, I.
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa Healthcare
- Published
- 2004-03
- Volume
- 3
- Issue
- 2
- Pages
- 81-83
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W4248399066
- Cited by
- 53
- References
- 0
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Unlicensed and off-label drug use in children: implications for safety. https://app.cochat.ai/papers/10.1517/14740338.3.2.81
- The paper
- Choonara, I. (2004). Unlicensed and off-label drug use in children: implications for safety. Expert Opinion on Drug Safety. https://doi.org/10.1517/14740338.3.2.81
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.